Price targets for Calian Group have been lifted into a cluster around CA$105 to CA$107, with fair value in one updated model moving from CA$94.07 to CA$106.25. That shift aligns with recent analyst commentary that is more positive on valuation and execution, while still highlighting the importance of the underlying assumptions. As you read on, you will see how these changing targets fit into the broader Calian Group story and how to track the evolving narrative over time.
What Wall Street Has Been Saying
🐂 Bullish Takeaways
-
RBC Capital lifted its Calian Group target to C$105 from C$90, which points to a more constructive view on valuation and the company's ability to execute on its plans.
-
CIBC analyst Stephanie Price raised the Calian Group target twice in recent months, first to C$93 from C$90, then to C$107 from C$93, and kept an Outperformer rating each time. This signals ongoing confidence in the story.
-
The tight cluster of updated targets around C$105 to C$107 suggests these firms see Calian Group's current business mix and pipeline as supporting a higher fair value in their models.
🐻 Bearish Takeaways
-
Even with higher targets, both RBC Capital and CIBC frame their views through detailed assumptions. This leaves room for downside risk if Calian Group's execution or end markets do not track those models.
-
The focus on target revisions rather than broadened coverage hints that investor attention could still be relatively limited, which may keep sentiment sensitive to future earnings or guidance surprises.
Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives!
We've flagged 1 risk for Calian Group. See which could impact your investment.
How This Changes the Fair Value For Calian Group
-
Fair value moved from CA$94.07 to CA$106.25 under the updated assumptions.
-
Revenue growth changed from 7.72% to 3.68% in the revised scenario.
-
Net profit margin moved from 3.41% to 4.49% in the new assumptions.
-
Future P/E shifted from 35.10x to 35.32x in the valuation models.
-
The discount rate changed from 6.35% to 6.44% in the updated analysis.
Never Miss an Update: Follow The Narrative
Narratives connect Calian Group's business story to analyst forecasts and fair value assumptions so you can see how headlines tie back to the numbers. They refresh as new data, contracts and guidance come through.
Head over to the Simply Wall St Community and follow the Narrative on Calian Group to stay up to date on:
-
How defense, space and cybersecurity, supported by a CA$1.5b backlog and a deal pipeline above CA$1b in Europe, shape Calian Group's revenue profile.
-
The role of healthcare contracts, including the AMS acquisition and expanded HCPR contract, as well as ongoing M&A across defense, healthcare and advanced tech in broadening earnings drivers.
-
Key risks such as ITCS segment underperformance, heavy exposure to government defense budgets, acquisition integration challenges, rising competition and higher compliance and talent costs.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include CGY.TO .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
